CytomX Therapeutics Inc (CTMX)
1.335
-0.02
(-1.84%)
USD |
NASDAQ |
Sep 21, 16:00
1.335
0.00 (0.00%)
After-Hours: 20:00
CytomX Therapeutics Price: 1.335 for Sept. 21, 2023
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Sep 20, 2023 | 1.36 | 1.38 | 1.32 | 1.36 | 193230.0 |
Sep 19, 2023 | 1.37 | 1.37 | 1.32 | 1.35 | 127619.0 |
Sep 18, 2023 | 1.38 | 1.40 | 1.35 | 1.37 | 143573.0 |
Sep 15, 2023 | 1.36 | 1.385 | 1.36 | 1.38 | 111843.0 |
Sep 14, 2023 | 1.39 | 1.400 | 1.35 | 1.38 | 107449.0 |
Sep 13, 2023 | 1.40 | 1.43 | 1.38 | 1.38 | 120238.0 |
Sep 12, 2023 | 1.38 | 1.41 | 1.38 | 1.40 | 68477.00 |
Sep 11, 2023 | 1.40 | 1.40 | 1.33 | 1.37 | 180379.0 |
Sep 08, 2023 | 1.36 | 1.39 | 1.34 | 1.39 | 157278.0 |
Sep 07, 2023 | 1.39 | 1.41 | 1.35 | 1.38 | 172544.0 |
Sep 06, 2023 | 1.44 | 1.44 | 1.38 | 1.38 | 214599.0 |
Sep 05, 2023 | 1.50 | 1.52 | 1.40 | 1.42 | 256759.0 |
Sep 01, 2023 | 1.49 | 1.54 | 1.48 | 1.50 | 129834.0 |
Aug 31, 2023 | 1.51 | 1.53 | 1.49 | 1.50 | 45224.00 |
Aug 30, 2023 | 1.45 | 1.50 | 1.43 | 1.49 | 252923.0 |
Aug 29, 2023 | 1.46 | 1.50 | 1.45 | 1.45 | 152192.0 |
Aug 28, 2023 | 1.45 | 1.49 | 1.45 | 1.45 | 28792.00 |
Aug 25, 2023 | 1.49 | 1.50 | 1.43 | 1.46 | 117923.0 |
Aug 24, 2023 | 1.53 | 1.53 | 1.46 | 1.48 | 152174.0 |
Aug 23, 2023 | 1.49 | 1.54 | 1.49 | 1.52 | 81469.00 |
Aug 22, 2023 | 1.46 | 1.51 | 1.46 | 1.48 | 69166.00 |
Aug 21, 2023 | 1.44 | 1.51 | 1.44 | 1.48 | 215618.0 |
Aug 18, 2023 | 1.46 | 1.52 | 1.45 | 1.47 | 207055.0 |
Aug 17, 2023 | 1.52 | 1.54 | 1.43 | 1.49 | 379376.0 |
Aug 16, 2023 | 1.59 | 1.61 | 1.52 | 1.54 | 264415.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.19
Minimum
Nov 15 2022
19.16
Maximum
Feb 25 2019
6.503
Average
6.73
Median
Oct 09 2019
Price Benchmarks
Apyx Medical Corp | 3.325 |
PetVivo Holdings Inc | 1.78 |
CymaBay Therapeutics Inc | 14.60 |
Intensity Therapeutics Inc | 3.67 |
NovaBay Pharmaceuticals Inc | 0.418 |
Price Related Metrics
PS Ratio | 1.337 |
Earnings Yield | -62.92% |
Market Cap | 89.14M |